RSA makes three appointments
October 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mateja Forstnaric, Nicholas Draeger, Stefanie Blasi, rsa
Life sciences executive search and interim management firm RSA has appointed three consultants to its European teams.
 Stefanie Blasi (pictured) …
European Medicines Group appoints two officers
October 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Garmon-Jones, EMG, Zinta Krumins
The European Medicines Group has elected new chairs to the body in David Garmon-Jones and Zinta Krumins, who will be …
Mayor of London calls for dementia R&D centre
October 8, 2014Research and Development, Sales and Marketing Alzheimer's, Boris Johnson, London, dementia, research
The mayor of London Boris Johnson is calling on both the government and the private sector to come together and …
Pharma ‘cannot deliver patient centricity’
October 8, 2014Research and Development, Sales and Marketing European Brain Council, barcelona, eyeforpharma, mary baker
The former president of the European Brain Council Mary Baker believes pharma companies are focussing too much on patient centricity, …
Verona Pharma appoints chief financial officer
October 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing roy biresh, verona pharma
London-based drug development firm Verona Pharma has hired Biresh Roy as its chief financial officer and member of the board …
Public opinion divided over UK drugs spend
October 7, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, UK, coalition, drugs spending, government
A new survey conducted for the ABPI shows that public opinion on whether the UK spends enough money on medicines …
BMS pulls hep C combo treatment in US
October 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Combo, HCV, asunaprevir, daclatasvir, hep C, sovaldi
Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current …
Triducive appoints senior account manager
October 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Triducive, ian walker, walker, warren
UK healthcare comms consultancy firm Triducive has appointed a new senior account manager in Ian Walker. Walker is a project …
Sovaldi ‘unaffordable’ says NHS documents
October 7, 2014Medical Communications, Research and Development, Sales and Marketing NHS England, fund, hep C, sovaldi
Senior health officials may have to bar Gilead’s new hepatitis C pill Sovaldi from being funded on the NHS after …
Galderma earns wrath of PMCPA in unprecedented case
October 7, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, Azzalure, Galderma, PMCPA, Pliaglis, UK, code of practise
Galderma has sensationally pulled out of the UK’s good conduct pact after the watchdog overseeing the ABPI Code found ‘extremely …
MRC commits £60m to new research projects
October 7, 2014Research and Development, Sales and Marketing MRC, NHS, Parkinson's, Parkinsons, UCL, experimental medicine challenge
Three new research programmes that aim to deliver a step-change in the understanding of disease by using human volunteers in …
Owen Mumford promotes and appoints
October 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Owen Mumford, Tracey walker, ceciilia mend, tania mackenzie
Medical device firm Owen Mumford is strengthening its marketing team with three new appointments. Two of the positions are …
Teva to ditch R&D in cancer and women’s health
October 6, 2014Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, MS, R&D, Teva, cuts, generics
Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …
Parexel acquires ClinIntel for trial supply services
October 6, 2014Manufacturing and Production CRO, Paraxel, clinical research organisation, clinintel, manufacturing
Clinical research organisation Parexel has acquired all of the outstanding equity securities of privately-owned ClinIntel, a UK-based provider of clinical …
Nobel Medicine Prize for ‘brain GPS’ discovery
October 6, 2014Medical Communications, Research and Development, Sales and Marketing
The Anglo-American John O’Keefe and Norwegian couple May-Britt and Edvard Moser have all won the 2014 Nobel Prize for medicine …
NHS England consults on Cancer Drugs Fund
October 6, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, NHS England, commissioning, oncology
NHS England is declaring new changes to the way the Cancer Drugs Fund operates in order to plug a major …
West to build new manufacturing plant in Ireland
October 6, 2014Manufacturing and Production Ireland, Pharma services, US, manufacturing, west
West Pharmaceutical Services which focusses on injectable drug administration, is expanding its global manufacturing operations to include a new site …
More patients self-diagnosing online
October 6, 2014Medical Communications, Sales and Marketing Facebook, GPs, Twitter, digital, online, self-diagnosing, social media
Prior to visiting doctors more people are utilising the internet and social media to determine an illness and its subsequent …
Gamification: what’s in it for the pharma industry?
October 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AF, Boehringer, COPD, CRUK, Gamification, ROI, Syrum, digital
Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This …
Astellas hires Americas president
October 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, brian mclellan
Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region. McLellan is to be …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
